AU2002313778A1 - Combined drug and csf removal therapies and systems - Google Patents
Combined drug and csf removal therapies and systemsInfo
- Publication number
- AU2002313778A1 AU2002313778A1 AU2002313778A AU2002313778A AU2002313778A1 AU 2002313778 A1 AU2002313778 A1 AU 2002313778A1 AU 2002313778 A AU2002313778 A AU 2002313778A AU 2002313778 A AU2002313778 A AU 2002313778A AU 2002313778 A1 AU2002313778 A1 AU 2002313778A1
- Authority
- AU
- Australia
- Prior art keywords
- systems
- combined drug
- csf removal
- removal therapies
- therapies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
- A61M3/0254—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
- A61M3/0258—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped by means of electric pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0464—Cerebrospinal fluid
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31393801P | 2001-08-21 | 2001-08-21 | |
US60/313,938 | 2001-08-21 | ||
PCT/US2002/026435 WO2003015710A2 (en) | 2001-08-21 | 2002-08-19 | Combined drug and csf removal therapies and systems |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002313778A1 true AU2002313778A1 (en) | 2003-03-03 |
Family
ID=23217836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002313778A Abandoned AU2002313778A1 (en) | 2001-08-21 | 2002-08-19 | Combined drug and csf removal therapies and systems |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002313778A1 (en) |
WO (1) | WO2003015710A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001289580A1 (en) | 2000-09-11 | 2002-03-22 | Csf Dynamics A/S | A fluid shunt system and a method for the treatment of hydrocephalus |
ES2307396B1 (en) * | 2006-09-14 | 2009-09-30 | Fundacion Para Investigaciones Neurologicas (Fin) | SYSTEMS FOR THE ELIMINATION OF NEUROTOXIC SUBSTANCES CAUSING NEURODEGENERATIVE DISEASES THROUGH THEIR SELECTIVE ATTACKING BY IMMUNOFINITY IN THE CIRCULATING CEPHALO-RAQUIDEO LIQUID. |
US10632237B2 (en) | 2006-10-09 | 2020-04-28 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
EP2086573B1 (en) | 2006-10-09 | 2020-11-25 | Neurofluidics, Inc. | Cerebrospinal fluid purification system |
US10850235B2 (en) | 2006-10-09 | 2020-12-01 | Minnetronix, Inc. | Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow |
WO2011114260A1 (en) | 2010-03-19 | 2011-09-22 | Pfizer Inc. | Cerebrospinal fluid purification system |
US20150038948A1 (en) * | 2013-07-31 | 2015-02-05 | G-Tech Electronic Research & Development, LLC | Apparatus and use of a neurochemisrty regulator device insertable in the cranium for the treatment of cerebral cortical disorders |
WO2015049588A2 (en) | 2013-10-01 | 2015-04-09 | Md Start Sa | Systems and methods for moving and circulating fluid to treat alzheimer's disease |
US11147540B2 (en) | 2015-07-01 | 2021-10-19 | Minnetronix, Inc. | Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue |
WO2017096228A1 (en) | 2015-12-04 | 2017-06-08 | Minnetronix, Inc. | Systems and methods for the conditioning of cerebrospinal fluid |
CN107088257B (en) * | 2017-04-27 | 2023-06-09 | 哈尔滨医科大学 | Y-shaped dual-purpose dual-cavity two-bag drainage device |
EP3826650A4 (en) | 2018-07-23 | 2022-07-27 | Enclear Therapies, Inc. | Methods of treating neurological disorders |
CN113164563A (en) | 2018-07-23 | 2021-07-23 | 因柯利尔疗法公司 | Method of treatment of neurological disorders |
EP3952947A1 (en) | 2019-04-11 | 2022-02-16 | Enclear Therapies, Inc. | Methods of amelioration of cerebrospinal fluid and devices and systems therefor |
US11559626B2 (en) * | 2020-04-08 | 2023-01-24 | Medtronic, Inc. | Means to treat Alzheimer's disease via flushing of brain parenchyma |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3134121B2 (en) * | 1989-10-11 | 2001-02-13 | バクスター インターナショナル インコーポレーテッド | Intracranial pressure monitor and drainage catheter assembly |
US5957912A (en) * | 1998-04-16 | 1999-09-28 | Camino Neurocare, Inc. | Catheter having distal stylet opening and connector |
US6193691B1 (en) * | 1999-03-30 | 2001-02-27 | Depuy Orthopaedics, Inc. | Catheter system |
US6913589B2 (en) * | 2002-01-14 | 2005-07-05 | Codman & Shurtleff, Inc. | Multi-catheter insertion device and method |
-
2002
- 2002-08-19 WO PCT/US2002/026435 patent/WO2003015710A2/en not_active Application Discontinuation
- 2002-08-19 AU AU2002313778A patent/AU2002313778A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003015710A2 (en) | 2003-02-27 |
WO2003015710A3 (en) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002341959A1 (en) | Drug delivery devices and methods | |
AU2002240275A1 (en) | Methods and devices for delivering occlusion elements | |
AU2002244142A1 (en) | Integrated medication delivery system | |
AU2002364897A1 (en) | Imiquimod therapies | |
AU6271401A (en) | Drug administering system and administering method | |
AU2003230845A1 (en) | Systems and methods for interventional medicine | |
AU2002243246A1 (en) | Cddo-compounds and combination therapies thereof | |
AU2003281876A1 (en) | Pharmaceutical delivery systems and methods for using same | |
AU2002347308A1 (en) | Secure collection and delivery system | |
AU2002326494A1 (en) | Products and drug delivery vehicles | |
AU2002343555A1 (en) | Eutectic-based self-nanoemulsified drug delivery system | |
AU2002361597A1 (en) | Combination spa and entertainment system | |
AU2002313778A1 (en) | Combined drug and csf removal therapies and systems | |
AUPR573001A0 (en) | Lymphatic drug delivery system | |
AU2002342053A1 (en) | Pancreatic cancer diagnosis and therapies | |
AU6196600A (en) | Medication reminder system | |
AU2002363522A1 (en) | System and method for improved computer drug design | |
GB0111496D0 (en) | Therapeutic systems and methods | |
AU2002222138A1 (en) | Drug delivery system | |
AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
WO2001046884A8 (en) | System for interdependent integration and aggregation | |
AU2002210580A1 (en) | Drug delivery system | |
AU2002319175A1 (en) | System and method for managing the administration of tecommunication | |
AU2002329204A1 (en) | Pharmaceutical detailing system | |
AU2002322833A1 (en) | Systems and methods to facilitate the delivery of drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |